General Information of the Compound
Compound ID
CP0572402
Compound Name
3-[3-(4-phenylpiperazin-1-yl)propyl]-1,3-benzoxazine-2,4-dione
    Show/Hide
Structure
Formula
C21H23N3O3
Molecular Weight
365.433
Canonical SMILES
O=c1oc2ccccc2c(=O)n1CCCN1CCN(CC1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C21H23N3O3/c25-20-18-9-4-5-10-19(18)27-21(26)24(20)12-6-11-22-13-15-23(16-14-22)17-7-2-1-3-8-17/h1-5,7-10H,6,11-16H2
    Show/Hide
InChIKey
FCMKRYXCALKDKH-UHFFFAOYSA-N
Physicochemical Property
logP
2.167
Rotatable Bonds
5
Heavy Atom Count
27
Polar Areas
58.69
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 56688316
ChEMBL ID
CHEMBL4878835
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 402 nM
   TI
   LI
   LO
   TS